Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07487792

Feasibility of Imaging Breast Implants With a Transmission-based Microwave Scanner

The goal of this clinical trial is to assess whether microwave scans can depict the presence of implants in the breast in women with existing breast implants that were surgically placed at least 6 months ago. The main questions it aims to answer are:

1. Can a microwave imaging device effectively scan a breast containing implants? 2. Can the presence of implants be identified in a microwave scan? 3. Can the microwave scans of the left and right breasts be compared to assess whether similarity is observed?

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Breast implants are consistently one of the top 5 cosmetic procedures performed each year in North America. The Food and Drug Administration (FDA) cites a 10% risk of rupture over 10 years (1% cumulative per annum risk of device rupture).

Rupture refers to disruption in the integrity of the implant, and is typically age-related deterioration where age in this context refer to the implant. Rupture in saline implants is detected with rapid change in breast size. With silicone implants, rupture is much more challenging to detect as it is rare to have a completely collapsed implant shell.

Current recommendations for surveillance of breast implants include Magnetic Resonance Imaging (MRI) or ultrasound within 5-6 years of surgery for the initial test, then every 2-3 years. The guideline initially included only MRI but was adjusted in 2022 to include ultrasound. Patient adherence to guidelines with only MRI was very low (less than 5%), which is postulated to relate to the expense, discomfort, and inaccessibility of MRI. Mammography is a frequently used breast imaging method. However, the majority of women with implants are too young for breast screening programs that involve regular mammograms. Also, the implant is displaced during mammography to focus on the breast tissues. Finally, mammography involves exposure to x-rays, limiting regular scans in women too young for screening.

Therefore, there is a need to regularly inspect silicone implants for silent rupture. An imaging approach that is low-cost, available at point-of-care, easy to use, and reliable (i.e. sensitive to implant rupture) would be a valuable tool for plastic surgery clinics.

Microwave imaging has been proposed as a low-cost and comfortable approach to breast imaging that can be performed at point of care. This approach to imaging is low power, so no tissue heating occurs and there are no other side effects. Therefore, microwave imaging is suited to in-clinic, ongoing monitoring of the breast.

10 women with breast implants will be recruited from plastic surgery clinics. This includes women with breast implants that were surgically placed at least 6 months prior and are asymptomatic for implant rupture, as well as women who have implants with a confirmed rupture. Study participants will be scanned with the microwave imaging system. Three scans of each breast will be collected in each of the Craniocaudal (CC) and Mediolateral Oblique (MLO) views.

The breast positioning will be adjusted between scans to maximize the presentation of the implant in the imaging volume. The images will be analyzed to identify the implants, as the implants have different properties when compared to healthy breast tissues.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women with breast implants placed at least 6 months prior who are asymptomatic for implant rupture as well as those with known implant rupture
  • Female
  • Minimum of 18 years of age
  • Able to provide informed consent

Exclusion criteria

  • Women who are currently pregnant or breastfeeding
  • Women with active breast infections
  • Women with nipple piercings (unless removed prior to scanning)
  • Women with implanted electronic device
  • Women with physical limitations that prevent them from placing their breasts inside the scanner

Treatment and study plan

WVI-MIS-03-2025

Device

Microwave scans

Primary outcomes

  1. Measurement of regions of interest in microwave images

    Time frame: 12 months

    Images of both breasts will be created. Regions of interest corresponding to the breast implants will be identified using the electrical properties. The size of these regions will be calculated.

Secondary outcomes

  1. Comparison of total area in implant in microwave image with known physical size

    Time frame: 12 months

    The total area corresponding to the breast implant in the microwave images will be calculated and compared with the known implant size.

  2. Compare microwave scans of the left and right breast

    Time frame: 12 months

    The properties and size of the region corresponding to the implant will be compared between right and left breasts.

Study contacts

Contact information is provided by the study sponsor or research team.

Anita Garland

CONTACT

[email protected]

403-703-1664

Elise Fear

CONTACT

[email protected]

403-210-5413

Sponsors and collaborators

Lead sponsor

University of Calgary

Other

Collaborators

  • Wave View Imaging Inc.

Registry information

Official study title

Feasibility of Imaging Breast Implants With a Transmission-based Transmission Scanner

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Mar 23, 2026
Registry last updated
Jun 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.